1. Home
  2. Analysis
  3. Baqsimi
  4. Hypoglycemia

Baqsimi and Hypoglycemia - a phase IV clinical study of FDA data

Summary:

Hypoglycemia is reported as a side effect among people who take Baqsimi (glucagon), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Humalog, and have Blood glucose decreased.

The phase IV clinical study analyzes which people have Hypoglycemia when taking Baqsimi. It is created by eHealthMe based on reports of 493 people who have side effects when taking Baqsimi from the FDA, and is updated regularly.

What is Baqsimi?

Baqsimi has active ingredients of glucagon. eHealthMe is studying from 493 Baqsimi users. Check the latest studies of Baqsimi.

What is Hypoglycemia?

Hypoglycemia (low blood sugar) is found to be associated with 1,708 drugs and 2,377 conditions by eHealthMe. Check the latest studies of Hypoglycemia.

On Jul, 11, 2026

493 people reported to have side effects when taking Baqsimi.
Among them, 64 people (12.98%) have Hypoglycemia.

Could Baqsimi cause Hypoglycemia?

Among these 64 people:

How long have people been on Baqsimi when they have Hypoglycemia? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Hypoglycemia when taking Baqsimi? *

  • female: 63.33 %
  • male: 36.67 %

What is the age of people who have Hypoglycemia when taking Baqsimi? *

  • 0-1: 0.0 %
  • 2-9: 3.03 %
  • 10-19: 12.12 %
  • 20-29: 6.06 %
  • 30-39: 6.06 %
  • 40-49: 9.09 %
  • 50-59: 18.18 %
  • 60+: 45.45 %

What are other drugs people take besides Baqsimi? *

  1. Humalog: 8 people, 12.50%
  2. Tresiba: 4 people, 6.25%
  3. Novolog: 3 people, 4.69%
  4. Trulicity: 2 people, 3.12%
  5. Fiasp: 2 people, 3.12%
  6. Actrapid: 2 people, 3.12%
  7. Oxycodone: 1 person, 1.56%
  8. Insulin: 1 person, 1.56%
  9. Basaglar: 1 person, 1.56%
  10. Crestor: 1 person, 1.56%

What are other side effects people have besides Hypoglycemia? *

  1. Drug Ineffective: 18 people, 28.12%
  2. Rhinalgia (pain in the nose): 9 people, 14.06%
  3. Headache (pain in head): 6 people, 9.38%
  4. Lacrimation Increased: 5 people, 7.81%
  5. Blood Glucose Decreased: 5 people, 7.81%
  6. Eye Pain: 4 people, 6.25%
  7. Loss Of Consciousness: 4 people, 6.25%
  8. Nausea (feeling of having an urge to vomit): 3 people, 4.69%
  9. Fatigue (feeling of tiredness): 3 people, 4.69%
  10. Nasal Discomfort: 3 people, 4.69%

What are the existing conditions these people have? *

  1. Blood Glucose Decreased: 20 people, 31.25%
  2. Type 1 Diabetes: 7 people, 10.94%
  3. Type 2 Diabetes: 2 people, 3.12%
  4. Diabetes: 2 people, 3.12%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 1.56%
  6. Hyperglycemia (high blood sugar): 1 person, 1.56%
  7. High Blood Cholesterol: 1 person, 1.56%

* Approximation only. Some reports may have incomplete information.

Do you take Baqsimi and have Hypoglycemia?

- Check whether Hypoglycemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Baqsimi:

Hypoglycemia treatments and more:

How severe was Hypoglycemia and when was it recovered:

Expand to all the drugs that have ingredients of glucagon:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Baqsimi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoglycemia:

Browse all the conditions that are associated with Hypoglycemia:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on glucagon (the active ingredients of Baqsimi) and Baqsimi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.